147 related articles for article (PubMed ID: 28335329)
1. Nanoparticle-Based Delivery of Anaplasma marginale Membrane Proteins; VirB9-1 and VirB10 Produced in the Pichia pastoris Expression System.
Zhang B; Cavallaro AS; Mody KT; Zhang J; Deringer JR; Brown WC; Mahony TJ; Yu C; Mitter N
Nanomaterials (Basel); 2016 Nov; 6(11):. PubMed ID: 28335329
[TBL] [Abstract][Full Text] [Related]
2. IgG and IgG2 antibodies from cattle naturally infected with Anaplasma marginale recognize the recombinant vaccine candidate antigens VirB9, VirB10, and elongation factor-Tu.
Araújo FR; Costa CM; Ramos CA; Farias TA; Souza II; Melo ES; Elisei C; Rosinha GM; Soares CO; Fragoso SP; Fonseca AH
Mem Inst Oswaldo Cruz; 2008 Mar; 103(2):186-90. PubMed ID: 18425271
[TBL] [Abstract][Full Text] [Related]
3. A partially purified outer membrane protein VirB9-1 for low-cost nanovaccines against Anaplasma marginale.
Zhao L; Cavallaro AS; Wibowo D; Zhang B; Zhang J; Mitter N; Yu C; Zhao CX; Middelberg AP
Vaccine; 2017 Jan; 35(1):77-83. PubMed ID: 27890399
[TBL] [Abstract][Full Text] [Related]
4. Association and evidence for linked recognition of type IV secretion system proteins VirB9-1, VirB9-2, and VirB10 in Anaplasma marginale.
Morse K; Norimine J; Palmer GH; Sutten EL; Baszler TV; Brown WC
Infect Immun; 2012 Jan; 80(1):215-27. PubMed ID: 22038917
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.
Zhao L; Mahony D; Cavallaro AS; Zhang B; Zhang J; Deringer JR; Zhao CX; Brown WC; Yu C; Mitter N; Middelberg AP
PLoS One; 2016; 11(4):e0154295. PubMed ID: 27115492
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.
Lopez JE; Palmer GH; Brayton KA; Dark MJ; Leach SE; Brown WC
Infect Immun; 2007 May; 75(5):2333-42. PubMed ID: 17339347
[TBL] [Abstract][Full Text] [Related]
7. Breadth of the CD4+ T cell response to Anaplasma marginale VirB9-1, VirB9-2 and VirB10 and MHC class II DR and DQ restriction elements.
Morse K; Norimine J; Hope JC; Brown WC
Immunogenetics; 2012 Jul; 64(7):507-23. PubMed ID: 22361828
[TBL] [Abstract][Full Text] [Related]
8. VirB10 vaccination for protection against Anaplasma phagocytophilum.
Crosby FL; Lundgren AM; Hoffman C; Pascual DW; Barbet AF
BMC Microbiol; 2018 Dec; 18(1):217. PubMed ID: 30563470
[TBL] [Abstract][Full Text] [Related]
9. A vaccine using Anaplasma marginale subdominant type IV secretion system recombinant proteins was not protective against a virulent challenge.
Sarli M; Novoa MB; Mazzucco MN; Signorini ML; Echaide IE; de Echaide ST; Primo ME
PLoS One; 2020; 15(2):e0229301. PubMed ID: 32084216
[TBL] [Abstract][Full Text] [Related]
10. Anaplasma marginale type IV secretion system proteins VirB2, VirB7, VirB11, and VirD4 are immunogenic components of a protective bacterial membrane vaccine.
Sutten EL; Norimine J; Beare PA; Heinzen RA; Lopez JE; Morse K; Brayton KA; Gillespie JJ; Brown WC
Infect Immun; 2010 Mar; 78(3):1314-25. PubMed ID: 20065028
[TBL] [Abstract][Full Text] [Related]
11. Cloning, sequencing and antigenic characterization of rVirB9 of Anaplasma marginale isolated from Paraná State, Brazil.
Vidotto MC; Venâncio EJ; Vidotto O
Genet Mol Res; 2008; 7(2):460-6. PubMed ID: 18561379
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of VirB8-VirB9-VirB10 interactions provides a dynamic model of type IV secretion system core complex assembly.
Sivanesan D; Hancock MA; Villamil Giraldo AM; Baron C
Biochemistry; 2010 Jun; 49(21):4483-93. PubMed ID: 20426418
[TBL] [Abstract][Full Text] [Related]
13. The Agrobacterium T-DNA transport pore proteins VirB8, VirB9, and VirB10 interact with one another.
Das A; Xie YH
J Bacteriol; 2000 Feb; 182(3):758-63. PubMed ID: 10633111
[TBL] [Abstract][Full Text] [Related]
14. Interactions of VirB9, -10, and -11 with the membrane fraction of Agrobacterium tumefaciens: solubility studies provide evidence for tight associations.
Finberg KE; Muth TR; Young SP; Maken JB; Heitritter SM; Binns AN; Banta LM
J Bacteriol; 1995 Sep; 177(17):4881-9. PubMed ID: 7665464
[TBL] [Abstract][Full Text] [Related]
15. Interactions between VirB9 and VirB10 membrane proteins involved in movement of DNA from Agrobacterium tumefaciens into plant cells.
Beaupré CE; Bohne J; Dale EM; Binns AN
J Bacteriol; 1997 Jan; 179(1):78-89. PubMed ID: 8981983
[TBL] [Abstract][Full Text] [Related]
16. High-throughput identification of T-lymphocyte antigens from Anaplasma marginale expressed using in vitro transcription and translation.
Lopez JE; Beare PA; Heinzen RA; Norimine J; Lahmers KK; Palmer GH; Brown WC
J Immunol Methods; 2008 Mar; 332(1-2):129-41. PubMed ID: 18243240
[TBL] [Abstract][Full Text] [Related]
17. Comparison of surface proteins of Anaplasma marginale grown in tick cell culture, tick salivary glands, and cattle.
Barbet AF; Blentlinger R; Yi J; Lundgren AM; Blouin EF; Kocan KM
Infect Immun; 1999 Jan; 67(1):102-7. PubMed ID: 9864202
[TBL] [Abstract][Full Text] [Related]
18. Vaccination of cattle with Anaplasma marginale derived from tick cell culture and bovine erythrocytes followed by challenge-exposure with infected ticks.
de la Fuente J; Kocan KM; Garcia-Garcia JC; Blouin EF; Claypool PL; Saliki JT
Vet Microbiol; 2002 Oct; 89(2-3):239-251. PubMed ID: 12243900
[TBL] [Abstract][Full Text] [Related]
19. Immunization of cattle with Anaplasma marginale derived from tick cell culture.
Kocan KM; Halbur T; Blouin EF; Onet V; de la Fuente J; Garcia-Garcia JC; Saliki JT
Vet Parasitol; 2001 Dec; 102(1-2):151-61. PubMed ID: 11705661
[TBL] [Abstract][Full Text] [Related]
20. Establishment of the tick (Acari:Ixodidae)-borne cattle pathogen Anaplasma marginale (Rickettsiales:Anaplasmataceae) in tick cell culture.
Munderloh UG; Blouin EF; Kocan KM; Ge NL; Edwards WL; Kurtti TJ
J Med Entomol; 1996 Jul; 33(4):656-64. PubMed ID: 8699463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
